Updated:
Cure Ventures
Cure Ventures is a life sciences venture capital firm focusing on investing in de novo company formation around groundbreaking curative technologies.
Cure Ventures
Cure Ventures is a life sciences venture capital firm focusing on investing in de novo company formation around groundbreaking curative technologies. The firm’s investment strategy is founded on three tenets: a seed funding model that allows Cure to de-risk the science and set companies up for success; genetic validation that increases the probability of success; and embedded Cure operators to drive day-to-day decision making with founders. With entrepreneurs, the firm aims to bring cures to life and save lives by funding and working alongside entrepreneurs developing therapeutics that cure life-altering diseases.
General information
Firm type
Venture Capital
Year founded
2021
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, United States
Principals
David Fallace
J.D. / M.B.A. — Managing Partner and Co-Founder
Richard J. Lim
M.B.A. — Managing Partner
William Amsbaugh
M.S. — CTO and Partner
Drew King
CPA / M.S.A. — CFO and Partner
Jeno Gyuris
Ph.D. — Partner
May Han
Ph.D. — Partner
Jeffrey M. Jonas
MD — Partner
Milenko Cicmil
Ph.D. — Venture Partner
Kayarash Karimian
Ph.D. — Senior Associate
Virginia Lyle King
Ph.D. — Senior Associate
Weihan Liu
Ph.D. — Associate
Albert J. Robichaud
Ph.D. — Partner
Sophie Robinson
Ph.D. — Senior Associate
Sector focus
Frequently asked questions
What is Cure Ventures?
Cure Ventures is a venture capital headquartered in Boston, United States.
When was Cure Ventures founded?
Cure Ventures was founded in 2021.
Where is Cure Ventures headquartered?
Cure Ventures is headquartered in Boston, United States, in the North America region.
What does Altss track for Cure Ventures?
Altss maintains an OSINT-verified profile of Cure Ventures covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Cure Ventures's website?
Cure Ventures's public website is www.curevc.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Cure Ventures?
Cure Ventures is classified by Altss as a Venture Capital, operating from United States within the North America region.
How does Altss source intelligence on Cure Ventures?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Cure Ventures's Altss profile last updated?
Cure Ventures's profile on Altss was last refreshed on August 11, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: